Fredun Pharma 39th AGM: all 11 resolutions passed, 7% dividend and bonus approved
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals held its 39th AGM on June 30, 2026 via video conferencing. All 11 resolutions passed with near-unanimous support, with about 24.25 lakh votes cast in favour. Key outcomes: 7% dividend declared for FY ending March 2026, bonus equity shares issue approved, authorised share capital increase approved, borrowing limit hike under Section 180(1)(c) approved, related party transactions and cost auditor remuneration approved. Whole Time Director Dr D N Medhora re-appointed by rotation.
Shareholders get 7% dividend plus bonus shares. Higher borrowing and investment limits give room for future expansion and fund-raising.